NCT03850795 2024-08-19HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)Hinova Pharmaceuticals USA, Inc.Phase 3 Terminated104 enrolled
NCT02378870 2016-06-30A Phase IIb Study to Evaluate Efficacy and Tolerability of ODX (Osteodex) in Metastatic CRPCDexTech Medical ABPhase 2 Terminated3 enrolled